5299 篇
13868 篇
408774 篇
16079 篇
9269 篇
3869 篇
6464 篇
1238 篇
72401 篇
37108 篇
12060 篇
1619 篇
2821 篇
3387 篇
640 篇
1229 篇
1965 篇
4866 篇
3821 篇
5293 篇
全球生物仿制药合同制造展望预测市场(2022-2027年)
Global Biosimilar Contract Manufacturing Market - Global Outlook Forecast 2022-2027
More than 2 billion people worldwide are not able to afford life-saving medicines, which puts their lives at risk. The rise in the development and commercialization of potentially life-saving drugs has made them more accessible and affordable. Also, the ease of accessibility to pharmaceutical drugs has minimized health inequality and enabled patients to live a better quality of life for a prolonged period. Although biologic drugs are at the forefront of therapeutic developments, their high-cost accounts for a significant portion of public and private drug expenditure worldwide. Comparatively, biosimilars are quite close in structure and function to biologic drugs and can prove to be more sustainable solutions at an affordable cost.
1 RESEARCH METHODOLOGY
2 RESEARCH OBJECTIVES
3 RESEARCH PROCESS
4 SCOPE & COVERAGE
5 REPORT ASSUMPTIONS & CAVEATS
6 MARKET AT A GLANCE
7 INTRODUCTION
8 PREMIUM INSIGHTS
9 MARKET OPPORTUNITIES & TRENDS
10 MARKET GROWTH ENABLERS